Keeping to the schedule

Scheduling decisions for ibuprofen, S3 melatonin, S3 fexofenadine and S2 brimonidine announced Decisions around the scheduling of a range of medicines have been announced with the release of interim decisions from the November 2022 meeting of the TGA's Advisory Committee on Medicines Scheduling (ACMS).  The TGA delegate rejected a proposal seeking the rescheduling from Schedule